Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Women with PCOS have more emotional and body image issues than healthy women.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

PCOS affects many women and requires early detection and symptom management.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Overweight women with PCOS are more likely to have excess male hormones.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Certain gene variants are linked to a higher risk of polycystic ovary syndrome, hair loss, and obesity in women from western Saudi Arabia.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

19.7% of Afro-Caribbean women in Tobago have PCOS.

PCOS may increase the risk of mental health issues like depression and anxiety.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.